Search
GRI Bio Inc
GRIAdd to Watchlist
1.930USD
+0.090+4.89%
Close 09-18 16:00（ET）
4.22MMarket Cap
LossP/E TTM
GRI Bio Inc (GRI) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to GRI Bio Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
153.500USD+8242.39%
GRI Analyst Recommendation Trends
In the current month, GRI has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. GRI average Analyst price target in the last month is 153.500.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
GRI Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, GRI EPS is projected to reach -0.980 in FY2026Q3, following reported EPS of -0.910 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-29.26
-0.91
-1.20
-0.98
-0.96
Actual
-13.25
-1.61
-0.91
--
--
Surprise
+54.72%
-77.90%
+23.83%
--
--
FAQs
What is GRI Bio Inc's price target?
Analysts forecast that GRI Bio Inc's price target is USD 153.50, with the highest forecast at USD 280.00 and the lowest forecast at USD 27.00.
How have GRI Bio IncGRI's recent earnings per share performed?
The market expectation was USD -0.91, while GRI Bio IncGRI's earnings per share (EPS) for the previous quarter was USD -1.61. EPS for the next quarter is expected at USD -0.98.
What is the analyst rating for GRI Bio Inc?
Based on the ratings of GRI Bio Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.